Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders

Details for Australian Patent Application No. 2012201911 (hide)

Owner Novartis AG

Inventors Tsai, Ruey-Shiuan

Agent Davies Collison Cave

Pub. Number AU-A-2012201911

Parent 2007287809

Filing date 2 April 2012

Wipo publication date 26 April 2012

International Classifications

A61K 31/436 (2006.01)

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

19 April 2012 Complete Application Filed

26 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201911

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201912-System and method for measuring an analyte in a sample

2012201910-A container assembly and a cap assembly for a container